Your point is well taken. Essentially, they're charging more for the cost recovery of the drug review, but the fee, the cost of drugs in the country, is lower generally.
On May 9th, 2017. See this statement in context.
On May 9th, 2017. See this statement in context.
Director General, Resource Management and Operations Directorate, Health Products and Food Branch, Department of Health
Your point is well taken. Essentially, they're charging more for the cost recovery of the drug review, but the fee, the cost of drugs in the country, is lower generally.
See context to find out what was said next.